Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine

Simple item page
dc.contributor.authorVan Regenmortel M.H.V.
dc.date.accessioned2012-01-18T08:06:36Z
dc.date.available2012-01-18T08:06:36Z
dc.date.issued2011
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.identifier.citationArchives of Virology
dc.identifier.citationhttp://www.scopus.com/inward/record.url?eid=2-s2.0-80054090258&partnerID=40&md5=efa93155f31e5672e7a789e95e1b8080
dc.identifier.issn3048608
dc.identifier.other10.1007/s00705-011-1145-2
dc.identifier.urihttp://hdl.handle.net/10019.1/19165
dc.titleRequirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine
dc.typeArticle in Press
Files
Collections
Stellenbosch University - Scopus Publications